Cboe Global Markets, Inc. - Common Stock (CBOE)

Today, BlackRock expanded its outcome ETF suite with the launch of the iShares Nasdaq Premium Income Active ETF (Nasdaq:BALQ). BALQ aims to provide current income while capturing the growth potential of innovation leaders in the Nasdaq 100 Index.

Franklin Templeton, a global investment leader with more than $1.6 trillion in assets under management, today announced that the Franklin Crypto Index ETF (Cboe: EZPZ) has expanded its holdings to include a broader set of digital assets following the latest reconstitution of the CF Institutional Digital Asset Index – US-Settlement Price. In addition to Bitcoin and Ether, EZPZ now incorporates XRP, Solana, Dogecoin, Cardano, Stellar Lumens, and Chainlink.

REX Shares (“REX”) and Tuttle Capital Management (“TCM”) announce the launch of two new leveraged ETFs: the T-REX 2X Long SOL Daily Target ETF (CBOE: SOLX) and the T-REX 2X Long XRP Daily Target ETF (CBOE: XRPK).

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that it has entered into an agreement to sell all of the ownership interests of its subsidiary engaged in the business of cultivating, producing, manufacturing, distributing and selling cannabis in the Commonwealth of Virginia to a subsidiary of Curaleaf Holdings Inc. (the “Transaction”) for total consideration of $110 million, subject to adjustment. The assets consist primarily of 5 active retail locations, 1 additional retail location in development, and approximately 82,000 square feet of cultivation and production capacity in the Richmond region.

VanEck is today announcing that it is once again extending the fee waiver for its VanEck Bitcoin ETF (HODL), which had previously been in place until January 10, 2026. The current waiver will now remain in effect through July 31, 2026. All other terms remain unchanged.

NEOS Investments, an asset management firm comprised of leaders and pioneers in the options-based ETF space, announces November monthly distribution amounts for their suite of ETFs that pursue monthly income and tax efficiency across core portfolio exposures.

The Cannabist Company (Cboe CA: CBST) (OTCQB: CBSTF) ("The Cannabist Company" or the "Company"), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the expansion of its partnership with Old Pal, a top-performing cannabis brand rooted in simplicity, quality and value, with the introduction of Old Pal flower products to medical patients in West Virginia.

REX Shares (“REX”), in collaboration with Tuttle Capital Management (“Tuttle”), is pleased to announce the launch of its newest leveraged single-stock ETF: the T-REX 2X Long CIFR Daily Target ETF (CBOE: CIFU), designed to deliver 200% of the daily performance of Cipher Mining (CIFR).

VanEck is introducing the VanEck Solana ETF (VSOL), offering investors exposure to SOL, the native token of the Solana network, and to the staking rewards earned for helping secure the network (please see the disclosures below for information related to staking).

This article has been disseminated on behalf of Cybin Inc. and may include paid advertising.

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today reported unaudited financial results for its second quarter ended September 30, 2025, and recent business highlights.

This article has been disseminated on behalf of Cybin Inc. and may include paid advertising.

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (”Cybin” or the “Company”), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that George Tziras, Cybin’s Chief Business Officer, will present at the Jefferies Global Healthcare Conference, taking place November 17-20, 2025, in London, UK.

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the third quarter ended September 30, 2025. All financial information presented in this release is in U.S. GAAP, unaudited, and in thousands of U.S. dollars, unless otherwise noted.

This article has been disseminated on behalf of Cybin Inc. and may include paid advertising.

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (”Cybin” or the “Company”), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 13, 2025, to provide a business update and report financial results for its second quarter ended September 30, 2025.

This article has been disseminated on behalf of Cybin Inc. and may include paid advertising.

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (”Cybin” or the “Company”), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that George Tziras, Cybin’s Chief Business Officer, will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference, taking place November 10-12, 2025, in Boston, MA.

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), today announced that it will report its financial results for the third quarter ended September 30, 2025 after U.S. financial markets close on Monday, November 10, 2025. Following the release of financial results, Company management will conduct a conference call at 4:30 p.m. EST.

ProShares, a premier provider of ETFs, announced today forward and reverse share splits on 22 of its ETFs. The splits will not change the total value of a shareholder’s investment.

Pacer Financial (Pacer) today announced a strategic partnership with financial technology firm Save®. Under the agreement, Pacer will serve as an investor and distribution partner for brokerage and wealth management channels of Save’s Liquid Market Savings Platform, an innovative cash-management solution that seeks to provide market-linked returns, daily liquidity, and extended FDIC insurance protection.

REX Financial (“REX”), a leader in innovative exchange-traded products, today announces the expansion of its Growth & Income Covered Call ETF suite with the launch of five new funds:

This article has been disseminated on behalf of Cybin Inc. and may include paid advertising.

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (”Cybin” or the “Company”), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that Amir Inamdar, Cybin’s Chief Medical Officer, will participate in a panel at the 2025 Milken Institute Future of Health Summit, taking place November 4-6, 2025, in Washington, D.C. The panel details are as follows:

Cybin Inc. (Cboe CA: CYBN) (NYSE American: CYBN) (“Cybin” or the “Company”), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, is pleased to announce that it has closed its previously announced registered direct offering of 22,277,750 common shares in the capital of the Company (a “Common Share”) and, in lieu of Common Shares to certain investors, 4,605,500 pre-funded Common Share purchase warrants (the “Pre-Funded Warrant”) at a price of US$6.51 per Common Share or Pre-Funded Warrant for aggregate gross proceeds of US$175,009,911.45 (the “Offering”).